Magazine: Are European biopharma manufacturers ‘nearshoring’?
Is 'nearshoring', the preference among pharma and biotech to move operations to the domestic markets versus outsourcing abroad, becoming the…
Analysis
Big pharma faces headwinds in China as vaccine sales decline
Rising Sirturo resistance highlights urgent need for new TB therapies
European agencies catch up with speedier regulatory pathways for CGTs in the US
Amid deglobalising trade, experts seek AI safeguards for clinical trial supply
Are European biopharma manufacturers ‘nearshoring’?
Inborn errors of metabolism elicit unique challenges for therapy development
Magazine: Radiopharmaceutical deals drive sector growth despite supply crisis
